NCT00487214View on ClinicalTrials.gov

Internet-based, Naturalistic Evaluation of Tolerability and Individual Patient Target Pressures With Bimatoprost 0.03% in Glaucoma

CompletedOBSERVATIONAL
Enrollment

361

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

February 28, 2003

Study Completion Date

February 28, 2003

Conditions
Glaucoma, Open-Angle
Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY